REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 212 filers reported holding REATA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,057 | +429.0% | 79,034 | +371.7% | 0.01% | +400.0% |
| Q1 2023 | $1,523 | +152.6% | 16,756 | +5.6% | 0.00% | – |
| Q4 2022 | $603 | -99.8% | 15,870 | +14.5% | 0.00% | – |
| Q3 2022 | $348,000 | -26.7% | 13,862 | -11.3% | 0.00% | – |
| Q2 2022 | $475,000 | -49.9% | 15,631 | -45.9% | 0.00% | -100.0% |
| Q1 2022 | $948,000 | -70.5% | 28,910 | -76.3% | 0.00% | 0.0% |
| Q4 2021 | $3,214,000 | +24.3% | 121,782 | +373.9% | 0.00% | 0.0% |
| Q3 2021 | $2,585,000 | +273.0% | 25,699 | +424.7% | 0.00% | – |
| Q2 2021 | $693,000 | -11.6% | 4,898 | -37.7% | 0.00% | – |
| Q1 2021 | $784,000 | +211.1% | 7,857 | +285.0% | 0.00% | – |
| Q4 2020 | $252,000 | +10.0% | 2,041 | -12.9% | 0.00% | – |
| Q3 2020 | $229,000 | -95.5% | 2,343 | -92.9% | 0.00% | -100.0% |
| Q2 2020 | $5,139,000 | -20.2% | 32,929 | -26.2% | 0.00% | -20.0% |
| Q1 2020 | $6,440,000 | -8.4% | 44,611 | +29.7% | 0.01% | +25.0% |
| Q4 2019 | $7,034,000 | +95.1% | 34,405 | -23.4% | 0.00% | +100.0% |
| Q3 2019 | $3,606,000 | -20.3% | 44,910 | -6.4% | 0.00% | -33.3% |
| Q2 2019 | $4,526,000 | +284.9% | 47,972 | +248.7% | 0.00% | +200.0% |
| Q1 2019 | $1,176,000 | +119.0% | 13,757 | +43.5% | 0.00% | – |
| Q4 2018 | $537,000 | -7.1% | 9,584 | +35.5% | 0.00% | – |
| Q3 2018 | $578,000 | +1309.8% | 7,073 | +505.6% | 0.00% | – |
| Q2 2018 | $41,000 | -52.9% | 1,168 | -72.3% | 0.00% | – |
| Q1 2018 | $87,000 | -12.1% | 4,216 | +20.6% | 0.00% | – |
| Q4 2017 | $99,000 | -18.9% | 3,496 | -11.0% | 0.00% | – |
| Q3 2017 | $122,000 | +1933.3% | 3,928 | +1924.7% | 0.00% | – |
| Q2 2017 | $6,000 | +50.0% | 194 | +9.0% | 0.00% | – |
| Q1 2017 | $4,000 | -81.0% | 178 | -81.9% | 0.00% | – |
| Q4 2016 | $21,000 | +2000.0% | 981 | +2551.4% | 0.00% | – |
| Q3 2016 | $1,000 | -99.2% | 37 | -99.4% | 0.00% | – |
| Q2 2016 | $120,000 | – | 6,084 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 3,063,567 | $298,453,000 | 49.63% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 150,000 | $14,613,000 | 19.62% |
| Corriente Advisors, LLC | 300,000 | $29,226,000 | 14.82% |
| Prosight Management, LP | 114,554 | $11,160,000 | 5.31% |
| MADDEN SECURITIES Corp | 43,927 | $4,279,000 | 3.18% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $2,958,000 | 2.24% |
| Biondo Investment Advisors, LLC | 99,652 | $9,708,000 | 2.10% |
| Cormorant Asset Management, LP | 450,000 | $43,839,000 | 1.69% |
| Duquesne Family Office | 543,901 | $52,987,000 | 1.54% |
| AWH Capital, L.P. | 9,500 | $925,000 | 1.30% |